{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:15:52Z","timestamp":1791393352294,"version":"4.3.3"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.patbio.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T02:52:44Z","timestamp":1278298364000},"page":"245-253","source":"Crossref","is-referenced-by-count":53,"title":["Hepatitis B virus: From diagnosis to treatment"],"prefix":"10.1016","volume":"58","author":[{"given":"P.","family":"D\u00e9ny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1872-034X.2009.00601.x","article-title":"Geographical and genetic diversity of the human hepatitis B virus","volume":"40","author":"Kurbanov","year":"2010","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"10.1016\/j.patbio.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/S1386-6532(05)80024-1","article-title":"The natural history of chronic hepatitis B virus infection","volume":"34","author":"Villeneuve","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u00a0\u2013\u00a0natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.patbio.2010.05.002_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"Liaw","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.patbio.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218339","article-title":"Hepatocellular carcinoma\u00a0\u2013\u00a0epidemiological trends and risk factors","volume":"27","author":"Schutte","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.patbio.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0b013e31816a342a","article-title":"Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study","volume":"85","author":"Freshwater","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.patbio.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.patbio.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","article-title":"Occult hepatitis B virus in liver tissue of individuals without hepatic disease","volume":"48","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.patbio.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/AAC.01318-07","article-title":"Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA","volume":"52","author":"Margeridon","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3324\/haematol.2009.005819","article-title":"Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance","volume":"94","author":"Ziakas","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cgh.2009.06.027","article-title":"Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression","volume":"7","author":"Palmore","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1423-0410.2001.00003.x","article-title":"An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques","volume":"80","author":"Saldanha","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.patbio.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2009.01.004","article-title":"Hepatitis D: 30years after","volume":"50","author":"Rizzetto","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virusres.2007.02.021","article-title":"Hepatitis B virus genetic variability and evolution","volume":"127","author":"Kay","year":"2007","journal-title":"Virus Res"},{"issue":"Suppl. 1","key":"10.1016\/j.patbio.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/PL00000061","article-title":"Constrained evolution with respect to gene overlap of hepatitis B virus","volume":"44","author":"Mizokami","year":"1997","journal-title":"J Mol Evol"},{"key":"10.1016\/j.patbio.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.patbio.2010.03.005","article-title":"Molecular biology of the hepatitis B virus and role of the X gene","volume":"58","author":"Wei","year":"2010","journal-title":"Pathol Biol (Paris)"},{"issue":"Pt 10","key":"10.1016\/j.patbio.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1099\/0022-1317-69-10-2575","article-title":"Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes","volume":"69","author":"Okamoto","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib20","doi-asserted-by":"crossref","unstructured":"Yu H, Yuan Q, Ge SX, et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype \u201cI\u201d. PLoS One 2010;5:e9297.","DOI":"10.1371\/journal.pone.0009297"},{"key":"10.1016\/j.patbio.2010.05.002_bib21","doi-asserted-by":"crossref","unstructured":"Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D, Mahanta J. A novel HBV recombinant (genotype I) similar to Vietnam\/Laos in a primitive tribe in Eastern India. J Viral Hepat 2010 [Epub ahead of print].","DOI":"10.1111\/j.1365-2893.2009.01206.x"},{"key":"10.1016\/j.patbio.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3201\/eid1411.080437","article-title":"Possible new hepatitis B virus genotype, South-East Asia","volume":"14","author":"Olinger","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.patbio.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/0022-1317-81-9-2267","article-title":"An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam","volume":"81","author":"Hannoun","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/JVI.02556-07","article-title":"New complex recombinant genotype of hepatitis B virus identified in Vietnam","volume":"82","author":"Tran","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1128\/JVI.00793-08","article-title":"When should \u201cI\u201d consider a new hepatitis B virus genotype?","volume":"82","author":"Kurbanov","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.21049","article-title":"Relationship of serological subtype, basic core promoter and precore mutations to genotypes\/subgenotypes of hepatitis B virus","volume":"80","author":"Kramvis","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1099\/0022-1317-83-11-2773","article-title":"The dominant hepatitis B virus genotype identified in Tibet is a C\/D hybrid","volume":"83","author":"Cui","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1099\/vir.0.018127-0","article-title":"A new hepatitis B virus subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV\/E strains","author":"Abdou Chekaraou","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2893.2005.00584.x","article-title":"Hepatitis B virus: significance of genotypes","volume":"12","author":"Schaefer","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.patbio.2010.05.002_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jmv.20545","article-title":"Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint-Denis district of Paris (France)","volume":"78","author":"Ganne-Carrie","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2893.1999.00174.x","article-title":"Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?","volume":"6","author":"Mayerat","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.patbio.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jhep.2003.50036","article-title":"Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease","volume":"37","author":"Sumi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.patbio.2010.05.002_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/174.5.920","article-title":"Hepatitis B virus (HBV)\/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F","volume":"174","author":"Casey","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.05.002_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jmv.1058","article-title":"Hepatitis delta virus genotypes I and III circulate associated with hepatitis B virus genotype F in Venezuela","volume":"64","author":"Quintero","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib36","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1099\/vir.0.013615-0","article-title":"Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region","volume":"90","author":"Gomes-Gouvea","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jmv.10126","article-title":"Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping","volume":"67","author":"Kato","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1872-034X.2008.00417.x","article-title":"HBV genotypes in India: do they influence disease severity?","volume":"39","author":"Madan","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.patbio.2010.05.002_bib39","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.3748\/wjg.15.5761","article-title":"Clinical relevance and public health significance of hepatitis B virus genomic variations","volume":"15","author":"Cao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.patbio.2010.05.002_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alpha-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2010.05.002_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jmv.10239","article-title":"Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan","volume":"68","author":"Kobayashi","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.05.002_bib42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1440-1746.2008.05718.x","article-title":"Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients","volume":"24","author":"Weigand","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0065-2423(08)00404-6","article-title":"Biomarkers of liver fibrosis","volume":"46","author":"Poynard","year":"2008","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.patbio.2010.05.002_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7150\/ijms.5.309","article-title":"Lamivudine treatment for severe acute HBV hepatitis","volume":"5","author":"Lisotti","year":"2008","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.patbio.2010.05.002_bib45","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1440-1746.2008.05600.x","article-title":"Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare","volume":"23","author":"Han","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib46","unstructured":"NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements 2008;25:1\u201329."},{"key":"10.1016\/j.patbio.2010.05.002_bib47","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.patbio.2010.05.002_bib48","doi-asserted-by":"crossref","unstructured":"van Bommel F, de Man RA, Wedemeyer H, et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues. Hepatology 2010;51:73\u201380.","DOI":"10.1002\/hep.23246"},{"key":"10.1016\/j.patbio.2010.05.002_bib49","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1053\/j.gastro.2005.03.009","article-title":"Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy","volume":"128","author":"Sung","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.patbio.2010.05.002_bib50","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/hep.22931","article-title":"Indications for therapy in hepatitis B","volume":"49","author":"Degertekin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.patbio.2010.05.002_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/eri.09.10","article-title":"Pathobiology of HBV mutants and clinical impact for treatment monitoring","volume":"7","author":"Si Ahmed","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 1","key":"10.1016\/j.patbio.2010.05.002_bib52","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2008.01.011","article-title":"Hepatitis B: reflections on the current approach to antiviral therapy","volume":"48","author":"Zoulim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1572-0241.2006.00418.x","article-title":"Treatment with PEG-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype","volume":"101","author":"Flink","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.patbio.2010.05.002_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/gut.2005.089722","article-title":"Predicting response to PEG-interferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B","volume":"56","author":"Bonino","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.patbio.2010.05.002_bib55","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2165\/10482940-000000000-00000","article-title":"Tenofovir disoproxil fumarate: in chronic hepatitis B","volume":"69","author":"Perry","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.patbio.2010.05.002_bib56","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.23145","article-title":"Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis","volume":"50","author":"Shim","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib57","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2165\/11319850-000000000-00000","article-title":"Predictors of treatment response in chronic hepatitis B","volume":"69","author":"Wong","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.patbio.2010.05.002_bib58","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.05.002_bib59","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.patbio.2010.05.002_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2007.12.024","article-title":"Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response","volume":"48","author":"Baldick","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2008.12.019","article-title":"Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B","volume":"51","author":"Zeuzem","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3851\/IMP1304","article-title":"Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir","volume":"14","author":"Kurashige","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.patbio.2010.05.002_bib63","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.09.068","article-title":"In vitro characterization of viral fitness of therapy-resistant hepatitis B variants","volume":"136","author":"Villet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.patbio.2010.05.002_bib64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2008.01.027","article-title":"Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure","volume":"48","author":"Villet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.patbio.2010.05.002_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811410000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811410000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:51:57Z","timestamp":1559227917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811410000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0369811410000635"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2010.05.002","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}